AAAAAA
Results:
1-17
|
Results: 17
Authors:
KNEIFEL B
BRUSADUWEL P
BECKER K
PLATZ D
ARNING M
KLEEBERG UR
Citation: B. Kneifel et al., ORAL DEXAMETHASONE FOR THE AMELIORATION OF THE GEMCITABINE-INDUCED SIDE-EFFECTS ASTHENIA, EDEMA, AND FLU-LIKE SYMPTOMS, Onkologie, 21(3), 1998, pp. 229-231
Authors:
LUFTNER D
FLATH B
AKRIVAKIS C
HANSGUNTHER M
OHNMACHT U
ARNING M
POSSINGER K
Citation: D. Luftner et al., GEMCITABINE PLUS DOSE-ESCALATED EPIRUBICIN IN ADVANCED BREAST-CANCER - RESULTS OF A PHASE-I STUDY, Investigational new drugs, 16(2), 1998, pp. 141-146
Authors:
WITHOLD W
ARNING M
SCHWARZ M
WOLF HH
SCHNEIDER W
Citation: W. Withold et al., MONITORING OF MULTIPLE-MYELOMA PATIENTS BY SIMULTANEOUSLY MEASURING MARKER SUBSTANCES OF BONE-RESORPTION AND FORMATION, Clinica chimica acta, 269(1), 1998, pp. 21-30
Authors:
BURK M
HEYLL A
ARNING M
VOLMER M
FARTASH K
SCHNEIDER W
Citation: M. Burk et al., PHARMACOKINETICS OF HIGH-DOSE CYTARABINE AND ITS DEAMINATION PRODUCT-A REAPPRAISAL, Leukemia & lymphoma, 27(3-4), 1997, pp. 321-327
Authors:
DAIKELER T
MAAS K
WEISS B
HARTMANN JT
KNOBLOCH A
ARNING M
KANZ L
BOKEMEYER C
Citation: T. Daikeler et al., THE INFLUENCE OF GEMCITABINE ON THE CD4 CD8 RATIO IN PATIENTS WITH SOLID TUMORS/, Oncology Reports, 4(3), 1997, pp. 561-564
Authors:
SUDHOFF T
WEHMEIER A
ARNING M
BAUSER U
SCHLOMER P
AUL C
SCHNEIDER W
Citation: T. Sudhoff et al., INCREASES OF SICAM-1 DURING NEUTROPENIC PNEUMONIA IN LEUKEMIC PATIENTS, Leukemia, 11(3), 1997, pp. 346-351
Authors:
SUDHOFF T
ARNING M
SCHNEIDER W
Citation: T. Sudhoff et al., PROPHYLACTIC STRATEGIES TO MEET INFECTIOUS COMPLICATIONS IN FLUDARABINE-TREATED CLL, Leukemia, 11, 1997, pp. 38-41
Authors:
ARNING M
BLATTER J
Citation: M. Arning et J. Blatter, GEMCITABINE IN SOLID TUMORS - PRESENT STATUS AND FURTHER DEVELOPMENT, Onkologie, 20(4), 1997, pp. 297-304
Authors:
WITHOLD W
ARNING M
SCHWARZ M
WOLF HH
SCHNEIDER W
REINAUER H
Citation: W. Withold et al., MONITORING OF THERAPEUTIC OUTCOME IN PATIENTS WITH MULTIPLE-MYELOMA BY SIMULTANEOUSLY MEASURING 3 DIFFERENT BIOCHEMICAL MARKERS OF BONE METABOLISM, Clinical chemistry, 42(6), 1996, pp. 722-722
Authors:
ARNING M
Citation: M. Arning, HEATING TIME REGULATION WITH THE HR-SOFT PROGRAM AND ELASTTIMER, Kautschuk und Gummi, Kunststoffe, 48(9), 1995, pp. 569
Authors:
HEERSONDERHOFF AH
ARNING M
WEHMEIER A
SUDHOFF T
ZUMDICK R
Citation: Ah. Heersonderhoff et al., NEUTROPHILIC DERMAL INFILTRATES IN GRANULOCYTOPENIC PATIENTS WITH ACUTE-LEUKEMIA, Annals of hematology, 71(5), 1995, pp. 257-261
Authors:
ARNING M
HEERSONDERHOFF AH
WEHMEIER A
SCHNEIDER W
Citation: M. Arning et al., PULMONARY TOXICITY DURING INFUSION OF LIPOSOMAL AMPHOTERICIN-B IN 2 PATIENTS WITH ACUTE-LEUKEMIA, European journal of clinical microbiology & infectious diseases, 14(1), 1995, pp. 41-43
Authors:
ARNING M
KLICHE KO
HEERSONDERHOFF AH
WEHMEIER A
Citation: M. Arning et al., INFUSION-RELATED TOXICITY OF 3 DIFFERENT AMPHOTERICIN-B FORMULATIONS AND ITS RELATION TO CYTOKINE PLASMA-LEVELS, Mycoses, 38(11-12), 1995, pp. 459-465
Authors:
DIEKKRUGER B
ARNING M
Citation: B. Diekkruger et M. Arning, SIMULATION OF WATER FLUXES USING DIFFERENT METHODS FOR ESTIMATING SOIL PARAMETERS, Ecological modelling, 81(1-3), 1995, pp. 83-95
Authors:
MCVOY CW
KERSEBAUM KC
ARNING M
KLEEBERG P
OTHMER H
SCHRODER U
Citation: Cw. Mcvoy et al., A DATA SET FROM NORTH GERMANY FOR THE VALIDATION OF AGROECOSYSTEM MODELS - DOCUMENTATION AND EVALUATION, Ecological modelling, 81(1-3), 1995, pp. 265-300
Authors:
ARNING M
AUL C
Citation: M. Arning et C. Aul, PROPHYLAXIS AGAINST MYCOSES IN GRANULOCYT OPENIC PATIENTS, Mycoses, 37, 1994, pp. 70-76
Authors:
KLICHE KO
WEHMEIER A
ARNING M
REUTER M
SCHNEIDER W
Citation: Ko. Kliche et al., DETERMINATION OF CYTOKINE PLASMA-LEVELS TO EVALUATE ADVERSE DRUG-REACTIONS TO 3 DIFFERENT PREPARATIONS OF AMPHOTERICIN-B, Blood, 82(10), 1993, pp. 10000502-10000502
Risultati:
1-17
|